That is very important, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be effective. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has been an experimental procedure (jeff brown market predictions). Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a development nearly nobody observed. But it's going to have profound implications for treating illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of investment opportunities in this area, too. Moving subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (artificial intelligence). That said, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly considerably prior to going higher - jeff brown 2020 predictions. I've been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mainly informing readers. But that's not the huge concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown biotech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are many fantastic private companies on the brink of striking the public markets And I have actually been dealing with a brand-new way for you to invest even before these business go public.
This opportunity has actually been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover out all the details. Go right here to schedule your area for complimentary.
Emma Walsh here, managing editor of the Diary. Routine Journal readers understand that tech isn't our usual beat (second wave). And when it concerns tech investing, we leave it to the specialists. Fortunately, we have numerous such specialists in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown top stock pick 2021). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the big image and predict what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and a lot more. These trends are experiencing exponential development and developing incredible chances for financiers. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. tech predictions. However despite what many readers might believe, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interrupted supply chains in 2015, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (what is the legacy report predicting). Losing two months of manufacturing and sales actually impacts the number of 5G devices are offered in the calendar year. When you think about all of that, offering 250 million systems is remarkable. More notably, the delays brought on by the pandemic developed a lots of suppressed demand. And that need is now going to be pushed into 2021. In reality, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown investment prediction. Which's not my only 5G prediction When I've discussed 5G in the past, I have actually described its 3 different phases.
In Stage 2, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Phase 3, 5G services start to be used (artificial intelligence). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summertime. This begins something of a virtuous cycle: The majority of people do not actually appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving cars, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment chances going forward will be massive. Stepping far from 5G, the next essential innovation I anticipate in 2021 is CRISPR genetic editing. CRISPR means "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a comparable concept however with our hereditary code. "Typos" in our genome can result in illness. CRISPR can correct these "typos." For several years, CRISPR was mostly a specific niche technology that wasn't well comprehended. And during that time, there were actually only three business running in this area. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with diseases and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This entire industry is successfully a greenfield opportunity.
There's room for many companies to exist in this area. social media. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its latest Alpha, Fold software application can properly predict the folding of a protein based entirely on its amino acid series with 92. 4% accuracy. That is essential because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however several drug treatments produced utilizing this technology. This was among those developments that practically no one discovered. However it's going to have extensive ramifications for curing illness. And, naturally, there will be lots of investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going higher. I've been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin - legacy report prediction. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. last year. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, however we could not separately confirm this claim. Given Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an exact figure at this moment. Brown is best known for his sage-like capability to select winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding perspective on the marketplace. He's constantly on the hunt for brand-new chances, and he shares a number of his best picks in the Future Report.
That's high praise, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he successfully forecasted some of the most significant economic occasions of the previous 20 years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, however Jeff Brown's precise forecasts have made him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research uses a number of research services with a wide range of expertises - jeff brown 2021 stock picks.
The business is likewise connected with Bonner & Partners, another well-respected research publisher - bleeding edge. On its site, Brownstone states its objective is to supply retail investors with professional-grade research: "For too long, the best financial investment research has not been readily available to individual investors. It has been normally booked for financial investment banks, hedge funds, private equity, and high-net-worth customers. exponential tech investor. The objective of Brownstone Research study is to make that type of proprietary research study readily available to any investors seeking to acquire an edge in the marketplaces. The objective is basic to provide distinct and lucrative financial investment research discovered no place else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the firm's Chief Investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After decades of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. jeff brown biotech stock pick for 2020. Everything he touches turns to gold! Jeff is well conscious of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown believes S.A.V. second wave. could be "the most significant trend of the 2020s, and he's not alone. Check out these quotes from other popular S.A.V. bulls: Elon's next big act will be marrying 2 innovative innovations: artificial intelligence and electrical vehicles. Musk hopes the mix will help him establish the first fully-autonomous, self-driving automobiles ever. It's nothing except the vehicle market's Holy Grail. As you understand, electric cars and self-driving car stocks have actually been big this year, but the Wall Street maker has approved buzz without much concrete result. In spite of an extreme increase in competitors over the past couple of years, Brown still believes Musk has the very best opportunity of putting it all together.
tech might be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Vehicle, and it might be the future of transportation. Generally, this technology would enable you to rent your car as an autonomous, self-driving taxi when you're not using it. You just get out of the cars and truck and press a button on an app that tells the car to "join the fleet." Next thing you know, you're unwinding on your couch while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty piece of the profits. It sounds insane, however it could be closed than you believe.